These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 8102048

  • 1. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS.
    Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
    [Abstract] [Full Text] [Related]

  • 2. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M.
    Psychiatry Res; 1992 Jul; 43(1):1-12. PubMed ID: 1332094
    [Abstract] [Full Text] [Related]

  • 3. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
    Owen RR, Gutierrez-Esteinou R, Hsiao J, Hadd K, Benkelfat C, Lawlor BA, Murphy DL, Pickar D.
    Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
    [Abstract] [Full Text] [Related]

  • 4. The MCPP challenge test in schizophrenia: hormonal and behavioral responses.
    Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM.
    Biol Psychiatry; 1991 Oct 15; 30(8):770-8. PubMed ID: 1751620
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serotonin function and treatment response to clozapine in schizophrenic patients.
    Kahn RS, Davidson M, Siever L, Gabriel S, Apter S, Davis KL.
    Am J Psychiatry; 1993 Sep 15; 150(9):1337-42. PubMed ID: 8394651
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH.
    Am J Psychiatry; 1994 Nov 15; 151(11):1626-30. PubMed ID: 7943451
    [Abstract] [Full Text] [Related]

  • 9. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.
    Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS.
    Arch Gen Psychiatry; 1994 Nov 15; 51(11):898-911. PubMed ID: 7944878
    [Abstract] [Full Text] [Related]

  • 10. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb 15; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
    Ghaziuddin N, King CA, Welch KB, Zaccagnini J, Weidmer-Mikhail E, Mellow AM, Ghaziuddin M, Greden JF.
    Psychiatry Res; 2000 Sep 11; 95(3):183-94. PubMed ID: 10974357
    [Abstract] [Full Text] [Related]

  • 15. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa.
    Levitan RD, Kaplan AS, Joffe RT, Levitt AJ, Brown GM.
    Arch Gen Psychiatry; 1997 Jun 11; 54(6):521-7. PubMed ID: 9193192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
    Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico C, Heninger GR, Charney DS.
    Psychiatry Res; 1991 Sep 11; 38(3):227-36. PubMed ID: 1754635
    [Abstract] [Full Text] [Related]

  • 18. Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.
    Lawlor BA, Sunderland T, Mellow AM, Hill JL, Molchan SE, Murphy DL.
    Arch Gen Psychiatry; 1989 Jun 11; 46(6):542-9. PubMed ID: 2730278
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression.
    Klaassen T, Riedel WJ, van Praag HM, Menheere PP, Griez E.
    Psychiatry Res; 2002 Dec 15; 113(1-2):29-40. PubMed ID: 12467943
    [Abstract] [Full Text] [Related]

  • 20. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
    Aloi JA, Insel TR, Mueller EA, Murphy DL.
    Life Sci; 1984 Apr 02; 34(14):1325-31. PubMed ID: 6708733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.